Health care firm expands with acquisition worth at least $125M

FORT MYERS —  NeoGenomics, a cancer-focused genetic testing services firm headquartered in Fort Myers, has completed the acquisition of the parent company of Genoptix Inc. of Carlsbad, Calif.

It paid $125 million in cash, as adjusted by working capital and other adjustments, and 1 million shares of NeoGenomics common stock, according to a release. Genoptix, a private company founded in 1999, is a leading clinical oncology laboratory specializing in hematology and solid tumor testing.